{"id":"oral-anti-diabetic-drug","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"null","effect":"Ketoacidosis"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved by binding to the GLP-1 receptor, which increases insulin secretion and decreases glucagon secretion. This results in improved glycemic control and reduced blood glucose levels.","oneSentence":"Works by stimulating the release of insulin from the pancreas.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:24:40.247Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT06263673","phase":"PHASE4","title":"Anti-Diabetic Medications to Fight PD and LBD","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2024-05-07","conditions":"Lewy Body Dementia, Parkinson Disease","enrollment":18},{"nctId":"NCT07351786","phase":"","title":"Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy","status":"RECRUITING","sponsor":"Sara A Belal","startDate":"2025-08-01","conditions":"Diabetes (DM), Retinopathy, Diabetic, Diabetic Retinopathy (DR)","enrollment":70},{"nctId":"NCT07279909","phase":"PHASE3","title":"Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hamdard University","startDate":"2024-03-09","conditions":"Diabetes Type 2, Diabetes Mellitus, Experimental, HbA1c","enrollment":500},{"nctId":"NCT07272993","phase":"NA","title":"Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hasanuddin University","startDate":"2025-10-20","conditions":"Diabetic Neuropathy, Diabetes Mellitus (DM), Functional Food","enrollment":102},{"nctId":"NCT05352815","phase":"PHASE3","title":"A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2022-06-01","conditions":"Diabetes Mellitus, Type 2","enrollment":1291},{"nctId":"NCT05013229","phase":"PHASE3","title":"A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-11-30","conditions":"Diabetes Mellitus, Type 2","enrollment":679},{"nctId":"NCT06269107","phase":"PHASE3","title":"A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-02-15","conditions":"Type 2 Diabetes","enrollment":485},{"nctId":"NCT05169060","phase":"PHASE1, PHASE2","title":"Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of Iowa","startDate":"2023-06-12","conditions":"Diabetic Neuropathies","enrollment":100},{"nctId":"NCT05259033","phase":"PHASE3","title":"A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2022-04-11","conditions":"Diabetes Mellitus, Type 2","enrollment":683},{"nctId":"NCT06830096","phase":"NA","title":"Role of KATP Channel Loss in Type 2 Diabetes","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-03-07","conditions":"Obesity and Type 2 Diabetes","enrollment":40},{"nctId":"NCT06845163","phase":"PHASE2","title":"Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2025-02-08","conditions":"Diabetic Macular Edema, Center-involved Diabetic Macular Edema","enrollment":56},{"nctId":"NCT06476730","phase":"NA","title":"Telerehabilitation Exercise: Effects on Maternal Psychological Health and Delivery Outcomes","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-07-01","conditions":"Gestational Diabetes Mellitus in Pregnancy, Gestational Diabetes, Maternal Psychological Distress","enrollment":62},{"nctId":"NCT06480292","phase":"NA","title":"Telerehabilitation Exercise: Effects on Maternal Quality of Life, Fetal and Neonatal Health.","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-07-01","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":68},{"nctId":"NCT06452017","phase":"NA","title":"Effects of Telerehabilitation Exercise Program on Maternal Glycemic Control","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-06-10","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":70},{"nctId":"NCT03471117","phase":"PHASE4","title":"Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients","status":"RECRUITING","sponsor":"The University of Texas at Arlington","startDate":"2018-04-01","conditions":"Chronic Kidney Diseases","enrollment":28},{"nctId":"NCT06992466","phase":"","title":"Short Term Outcomes After Primary PCI in Diabetic Patients Treated With Insulin Versus Oral Anti-diabetic Drugs","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-05-20","conditions":"Diabetes Mellitus, PCI","enrollment":210},{"nctId":"NCT06974422","phase":"NA","title":"Weight Off-loading Training, Cardiovascular Indices, Diabetes","status":"COMPLETED","sponsor":"Umm Al-Qura University","startDate":"2024-08-01","conditions":"Cardiovascular Disease, Diabetes Mellitus Type 2, Peripheral Vascular Disorder Due to Diabetes Mellitus","enrollment":46},{"nctId":"NCT04451980","phase":"","title":"The HIV, Adipose Tissue Immunology, and Metabolism Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2017-08-31","conditions":"Hiv, Diabetes Mellitus, Type 2","enrollment":172},{"nctId":"NCT06725238","phase":"","title":"Acute-to-chronic Glycemic Ratio (ACGR) is a Marker of DFUs .","status":"COMPLETED","sponsor":"University of Diyala","startDate":"2024-05-01","conditions":"Diabetic Foot Ulcer (DFU)","enrollment":80},{"nctId":"NCT04227431","phase":"","title":"A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in China","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-01-17","conditions":"Diabetes Mellitus, Type 2","enrollment":938},{"nctId":"NCT03653091","phase":"NA","title":"Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes","status":"COMPLETED","sponsor":"Fractyl Health Inc.","startDate":"2018-09-28","conditions":"Type 2 Diabetes","enrollment":9},{"nctId":"NCT00455858","phase":"PHASE4","title":"Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":87},{"nctId":"NCT04575181","phase":"PHASE1","title":"A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-10-21","conditions":"Diabetes Mellitus, Type 2","enrollment":86},{"nctId":"NCT04233801","phase":"PHASE3","title":"A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-04-15","conditions":"Diabetes Mellitus, Type 2","enrollment":219},{"nctId":"NCT01431807","phase":"PHASE3","title":"Long-term Study of SYR-472","status":"COMPLETED","sponsor":"Takeda","startDate":"2011-09-01","conditions":"Diabetes Mellitus","enrollment":680},{"nctId":"NCT05946148","phase":"","title":"Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2018-06-01","conditions":"Non-Alcoholic Fatty Liver Disease, Liver Steatosis","enrollment":78},{"nctId":"NCT05005052","phase":"PHASE3","title":"Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities","status":"UNKNOWN","sponsor":"Value Outcomes Ltd.","startDate":"2021-11-25","conditions":"Chronic Venous Disease, Chronic Insufficiency Venous","enrollment":290},{"nctId":"NCT05333835","phase":"PHASE2","title":"A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2022-07-08","conditions":"Type 2 Diabetes","enrollment":455},{"nctId":"NCT05822674","phase":"","title":"Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio","status":"COMPLETED","sponsor":"University of Diyala","startDate":"2022-01-01","conditions":"Type 2 Diabetes","enrollment":80},{"nctId":"NCT03871621","phase":"PHASE4","title":"Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2019-04-01","conditions":"Type 2 Diabetes Mellitus","enrollment":76},{"nctId":"NCT03714594","phase":"PHASE2","title":"Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.","status":"COMPLETED","sponsor":"University of Pisa","startDate":"2018-07-24","conditions":"Type2 Diabetes Mellitus","enrollment":48},{"nctId":"NCT05558878","phase":"NA","title":"Effect of Ambroxol in Diabetic Peripheral Neuropathy","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2022-10-01","conditions":"Diabetic Neuropathy Peripheral","enrollment":80},{"nctId":"NCT05310916","phase":"PHASE3","title":"Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Nidae Alaa","startDate":"2022-06-06","conditions":"Diabetic Retinopathy","enrollment":60},{"nctId":"NCT02842359","phase":"PHASE4","title":"Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-08-23","conditions":"Type 2 Diabetes Mellitus","enrollment":11},{"nctId":"NCT03434119","phase":"PHASE3","title":"Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents","status":"TERMINATED","sponsor":"Sanofi","startDate":"2018-02-20","conditions":"Type 2 Diabetes Mellitus","enrollment":241},{"nctId":"NCT02787551","phase":"PHASE3","title":"Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-07-06","conditions":"Type 2 Diabetes Mellitus","enrollment":514},{"nctId":"NCT04976283","phase":"PHASE4","title":"Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver","status":"UNKNOWN","sponsor":"Getz Pharma","startDate":"2021-09-15","conditions":"Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis, NAFLD","enrollment":123},{"nctId":"NCT05145140","phase":"PHASE1","title":"A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer","status":"UNKNOWN","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-01-15","conditions":"Diabetic Foot Ulcer","enrollment":80},{"nctId":"NCT04385589","phase":"PHASE4","title":"Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure","status":"COMPLETED","sponsor":"Assiut University","startDate":"2020-05-01","conditions":"Heart Failure","enrollment":100},{"nctId":"NCT04323462","phase":"PHASE4","title":"Intensive Glycemic Control For Diabetic Foot Ulcer Healing","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2021-10-01","conditions":"Diabetic Foot Ulcer","enrollment":326},{"nctId":"NCT02874313","phase":"PHASE4","title":"CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea","status":"COMPLETED","sponsor":"Hospital Universitario La Paz","startDate":"2016-08","conditions":"Diabetic Retinopathy, Sleep Apnea","enrollment":82},{"nctId":"NCT02911948","phase":"PHASE3","title":"A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2016-09-21","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":210},{"nctId":"NCT03824379","phase":"PHASE2","title":"Magnesium Supplementation in Diabetic Nephropathy","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2019-06-01","conditions":"Diabetic Nephropathies","enrollment":60},{"nctId":"NCT04123587","phase":"PHASE4","title":"Genetic Variants Replication Study Associated With Dependence on Sulfonylurea in Participants With Type 2 Diabetes","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2019-09-10","conditions":"Diabetes Mellitus","enrollment":58},{"nctId":"NCT02749890","phase":"PHASE3","title":"Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-05-09","conditions":"Type 2 Diabetes Mellitus","enrollment":321},{"nctId":"NCT02752828","phase":"PHASE3","title":"Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-05-23","conditions":"Type 2 Diabetes Mellitus","enrollment":521},{"nctId":"NCT04381598","phase":"PHASE2","title":"Stevia Rebaudiana Bertoni on Levels of GCF Glucose and Bio-markers in Diabetics.","status":"UNKNOWN","sponsor":"SVS Institute of Dental Sciences","startDate":"2019-04-01","conditions":"Periodontitis","enrollment":19},{"nctId":"NCT02925559","phase":"PHASE4","title":"Effect of Anti-diabetic Drugs on Glycemic Variability","status":"COMPLETED","sponsor":"Centro de Diabetes Curitiba Ltda","startDate":"2016-10","conditions":"Diabetes Mellitus, Type 2","enrollment":135},{"nctId":"NCT02226822","phase":"","title":"DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-09-20","conditions":"Type 2 Diabetes Mellitus","enrollment":1869},{"nctId":"NCT04161404","phase":"PHASE1","title":"Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition","status":"UNKNOWN","sponsor":"University of Malaya","startDate":"2019-08-21","conditions":"Pharmacokinetics, Molecular Mechanisms of Pharmacological Action","enrollment":18},{"nctId":"NCT04207541","phase":"NA","title":"Promoting Insulin Initiation Among Suboptimal Diabetic Control Patients","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2019-10-01","conditions":"Type 2 Diabetes","enrollment":130},{"nctId":"NCT02501772","phase":"NA","title":"The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy","status":"UNKNOWN","sponsor":"Mackay Memorial Hospital","startDate":"2014-09","conditions":"Diabetic Nephropathy","enrollment":60},{"nctId":"NCT03665350","phase":"PHASE2","title":"Insulin Treatment in Diabetic Older People With Heart Failure.","status":"TERMINATED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2018-11-08","conditions":"Heart Failure, Diabetes Mellitus, Type 2","enrollment":10},{"nctId":"NCT04141163","phase":"PHASE1, PHASE2","title":"Metformin in Patients With Fragile X","status":"UNKNOWN","sponsor":"Rowan University","startDate":"2019-10-29","conditions":"Fragile X Syndrome","enrollment":40},{"nctId":"NCT04143321","phase":"PHASE4","title":"Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2018-09-10","conditions":"Diabetes Mellitus","enrollment":75},{"nctId":"NCT04120259","phase":"NA","title":"Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2019-04-22","conditions":"Diabetes Mellitus, Type 2","enrollment":126},{"nctId":"NCT03191396","phase":"PHASE3","title":"Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2017-06-27","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":577},{"nctId":"NCT00888836","phase":"NA","title":"Diet and Medical Therapy Versus Bariatric Surgery in Type 2 Diabetes","status":"COMPLETED","sponsor":"Catholic University of the Sacred Heart","startDate":"2009-04","conditions":"Type 2 Diabetes","enrollment":60},{"nctId":"NCT02060383","phase":"PHASE4","title":"Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2014-05-23","conditions":"Cushing's Disease, Acromegaly","enrollment":249},{"nctId":"NCT00282971","phase":"PHASE3","title":"A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus","status":"TERMINATED","sponsor":"Pfizer","startDate":"2006-03-06","conditions":"Diabetes Mellitus Type 2","enrollment":354},{"nctId":"NCT02453685","phase":"PHASE4","title":"A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2015-08-31","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":335},{"nctId":"NCT02954692","phase":"PHASE4","title":"A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-11-30","conditions":"Type 2 Diabetes Mellitus","enrollment":112},{"nctId":"NCT02606357","phase":"PHASE4","title":"Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-11-22","conditions":"Diabetes Mellitus, Type 2","enrollment":242},{"nctId":"NCT02738151","phase":"PHASE4","title":"Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-05-19","conditions":"Diabetes Mellitus, Type 2","enrollment":929},{"nctId":"NCT03602846","phase":"","title":"Diabetes in Pregnancy and Pregnancy Outcomes","status":"COMPLETED","sponsor":"Tarumanagara University","startDate":"2015-01","conditions":"Diabetes Mellitus in Pregnancy, Diabetes, Gestational","enrollment":45},{"nctId":"NCT02168816","phase":"PHASE2","title":"Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis","status":"TERMINATED","sponsor":"Loyola University","startDate":"2014-03-19","conditions":"Osteomyelitis","enrollment":30},{"nctId":"NCT03196154","phase":"","title":"Association Between Insulin Resistance and Beta Cell Function With HbA1C in Diabetics","status":"COMPLETED","sponsor":"Clinical Research Centre, Malaysia","startDate":"2017-08-01","conditions":"Diabetes Mellitus, Type 2","enrollment":255},{"nctId":"NCT01336023","phase":"PHASE3","title":"Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2011-05-23","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":1663},{"nctId":"NCT03398577","phase":"PHASE4","title":"Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2018-02-01","conditions":"Coronary Disease With Diabetes Mellitus","enrollment":61},{"nctId":"NCT01512108","phase":"PHASE3","title":"Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2012-01-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":363},{"nctId":"NCT01128621","phase":"PHASE2","title":"A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-11-23","conditions":"Diabetes Mellitus, Type 2","enrollment":66},{"nctId":"NCT03169959","phase":"PHASE1","title":"A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2017-05-29","conditions":"Type 2 Diabetes Mellitus","enrollment":85},{"nctId":"NCT01848379","phase":"NA","title":"White Blood Cell Signaling and Defense Mechanisms in Patients With Diabetes Mellitus Type 2 and Periodontitis","status":"UNKNOWN","sponsor":"Zentrum fuer Zahn-, Mund- und Kieferheilkunde","startDate":"2012-01","conditions":"Chronic Periodontitis, Diabetes Mellitus, Type 2","enrollment":45},{"nctId":"NCT01798706","phase":"PHASE3","title":"Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":350},{"nctId":"NCT00642616","phase":"PHASE3","title":"Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease","status":"TERMINATED","sponsor":"Mannkind Corporation","startDate":"2009-03","conditions":"Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Moderate Chronic Obstructive Pulmonary Disease","enrollment":34},{"nctId":"NCT00116831","phase":"PHASE3","title":"Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-01","conditions":"Atherosclerosis","enrollment":672},{"nctId":"NCT01272193","phase":"PHASE3","title":"Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2011-01","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":296},{"nctId":"NCT00537303","phase":"PHASE4","title":"Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":296},{"nctId":"NCT01364428","phase":"PHASE3","title":"Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2011-06","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":373},{"nctId":"NCT01165684","phase":"PHASE4","title":"Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":401},{"nctId":"NCT01880736","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-06","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":458},{"nctId":"NCT00982644","phase":"PHASE3","title":"Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-09","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":1030},{"nctId":"NCT01068652","phase":"PHASE4","title":"Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":403},{"nctId":"NCT00184561","phase":"PHASE4","title":"Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-07","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":321},{"nctId":"NCT00842192","phase":"","title":"An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":2155},{"nctId":"NCT02585674","phase":"PHASE3","title":"Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-12","conditions":"Type 2 Diabetes Mellitus","enrollment":151},{"nctId":"NCT02958579","phase":"","title":"a Population Based Study on Metabolic Syndrome Complications, and Mortality","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2005-01","conditions":"Metabolic Syndrome X","enrollment":10000},{"nctId":"NCT00715780","phase":"","title":"Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-06","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":1667},{"nctId":"NCT01679899","phase":"PHASE4","title":"Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability","status":"COMPLETED","sponsor":"Centro de Diabetes Curitiba Ltda","startDate":"2012-12","conditions":"Type 2 Diabetes Mellitus, Menopause, Osteoporosis","enrollment":56},{"nctId":"NCT02476760","phase":"","title":"Incretin-based Drugs and Acute Pancreatitis","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Diabetes Mellitus, Type 2","enrollment":1417914},{"nctId":"NCT01086306","phase":"","title":"Risk of Hospitalized Infections Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatment","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-01","conditions":"Diabetes Mellitus, Type 2","enrollment":113505},{"nctId":"NCT02802644","phase":"PHASE4","title":"The Effect of DPP4 Inhibitor on Vasclular Healing","status":"UNKNOWN","sponsor":"Chung-Ang University","startDate":"2016-06","conditions":"Acute Coronary Syndrome, Diabetes Mellitus, Type 2","enrollment":66},{"nctId":"NCT00478595","phase":"PHASE3","title":"Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug","status":"TERMINATED","sponsor":"Sanofi","startDate":"2007-04","conditions":"Obesity, Diabetes Mellitus Type 2","enrollment":458},{"nctId":"NCT02456428","phase":"","title":"Incretin-based Drugs and the Risk of Heart Failure","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Type 2 Diabetes Mellitus","enrollment":1499650},{"nctId":"NCT00491725","phase":"PHASE4","title":"Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-09","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":187},{"nctId":"NCT01135992","phase":"PHASE3","title":"Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-06","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":143},{"nctId":"NCT01922492","phase":"NA","title":"Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug.","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2008-05","conditions":"Partial Pancreatectomy Due to Benign Pancreatic Neoplasm","enrollment":28},{"nctId":"NCT02587741","phase":"EARLY_PHASE1","title":"Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-07","conditions":"Diabetic Retinopathy","enrollment":600}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"CONVULSION"},{"count":1,"reaction":"ELECTROENCEPHALOGRAM ABNORMAL"},{"count":1,"reaction":"WRONG TECHNIQUE IN DRUG USAGE PROCESS"}],"_approvalHistory":[],"publicationCount":103,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Glucose lowering"],"phase":"phase_3","status":"active","brandName":"oral anti-diabetic drug","genericName":"oral anti-diabetic drug","companyName":"Novo Nordisk A/S","companyId":"novo-nordisk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Works by stimulating the release of insulin from the pancreas. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}